Salim Virani, MD, PhD, staff cardiologist at the Michael E. DeBakey VA Medical Center in Houston, vice provost for research and professor at the Aga Khan University in Karachi, Pakistan, and staff at The Texas Heart Institute/Baylor College of Medicine.
News | Peripheral Artery Disease (PAD)
Targeted Reminders Increase Prescriptions for High-Intensity Statins

March 5, 2023 — Patients with cardiovascular disease, such as heart disease, stroke or peripheral arterial disease, were ...

Home March 05, 2023
Home
Tor Biering-Sørensen, MD, MSc, MPH, PhD, professor, Center for Translational Cardiology and Pragmatic Randomized Trials, Copenhagen University Hospital,
News | ACC
Linking Flu Vaccination to Potential Cardiovascular Benefits Gets More People to Roll Up Their Sleeves

March 5, 2023 — Making a connection between the flu and the risk of subsequent heart problems significantly increased ...

Home March 05, 2023
Home
Amrita Mukhopadhyay, MD, cardiologist and clinical investigator at NYU Grossman School of Medicine in New York City
News | Heart Failure
Prescribing of Key Heart Failure Medications Improved with Tailored Digital Alerts

March 5, 2023 — Doctors who received customized electronic health record (EHR) alerts for specific patients were 2.5 ...

Home March 05, 2023
Home
John K. Forrest, MD, director of interventional cardiology and structural heart disease at Yale University School of Medicine
News | Cardiovascular Clinical Studies
Benefits of TAVR Remain Consistent in Patients at Low Surgical Risk at Three Years

March 5, 2023 — The number of deaths and disabling strokes among patients at low surgical risk who were treated with ...

Home March 05, 2023
Home
Nearly 40% risk reduction seen with intravascular imaging compared with angiography alone
News | Intravascular Imaging
Stenting With Close Look Inside Blood Vessel Improves Outcomes in Patients with Complex Coronary Artery Disease

March 5, 2023 — Patients with complex coronary artery disease who underwent a stenting procedure guided by intravascular ...

Home March 05, 2023
Home
In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents in all diseased arteries was found to be as safe and effective at one year of follow-up as staged treatment, according to findings from the first large, randomized trial to address this question that is being presented at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology.
News | Stents
Immediate Complete Revascularization as Safe and Effective as Staged Procedure in Treating Multi-Vessel Disease

March 5, 2023 — In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents ...

Home March 05, 2023
Home
COAPT trial demonstrates long-term benefits of transcatheter procedure in high-risk patients with heart failure
News | Structural Heart
Minimally Invasive Mitral Valve Repair Reduces Hospitalizations and Deaths

March 5, 2023 — In patients with heart failure and a poorly functioning heart valve, a minimally invasive procedure ...

Home March 05, 2023
Home
Newer technique is equally safe and effective when performed by experienced surgeons, according to investigators
News | Cardiovascular Clinical Studies
Similar Recovery Seen for Patients Receiving Minimally Invasive and Conventional Surgery for Mitral Valve Repair

March 5, 2023 — In the largest randomized trial conducted to compare minimally invasive and conventional cardiac ...

Home March 05, 2023
Home
The Opening Showcase of the American College of Cardiology's Annual Scientific Session Together with the World Congress of Cardiology, ACC.23/WCC, featured comments from Ed Fry, MD, ACC President, shown here, the event Chair and World Heart Federation President. the 3-day global gathering of cardiologists is taking place March 4-6 in New Orleans, LA.
Feature | ACC | Christine Book
Important Clinical Trial Outcomes, the Evolution of Cardiac ICU and Young Authors Take Center Stage for Global Gathering of Cardiologists in New Orleans ACC.23/WCC

March 4, 2023 — Of the immense volume of valuable information offered and exchanged during the first day of the American ...

Home March 04, 2023
Home
ACC23 Stop CA trial image
News | ACC
STOP-CA Clinical Trial Finds Statins Lower Rate of Heart Decline in Lymphoma Patients, Late-Breaking ACC23 Clinical Trial Reports

March 4, 2023 — The impact of statin use to prevent heart damage during a cancer patient’s chemotherapy was in focus ...

Home March 04, 2023
Home
ACC23 Triluminate trial image
News | ACC
TRILUMINATE Pivotal Trial Findings Reported at ACC.23/WCC Reveal Impact of Improved Tricuspid Valve Functioning

March 4, 2023 — Findings from the TRILUMINATE Pivotal Trial found no significant difference in survival or ...

Home March 04, 2023
Home
Statistically significant reduction in the risk for the primary outcome on Day 27
News | Heart Failure
New Analyses of Sotagliflozin Showing Time to Clinical Benefit Presented at ACC23

March 4, 2023 - Lexicon Pharmaceuticals, Inc. announced new analyses of results from the SOLOIST-WHF Phase 3 outcomes ...

Home March 04, 2023
Home
Viz.ai’s AI-powered clinical research platform will be used to find, screen and enroll patients in a landmark study of catheter-directed therapy for pulmonary embolism
News | Artificial Intelligence
Viz.ai to Expedite Patient Enrollment in NIH-funded PE-TRACT Clinical Trial

March 4, 2023 — Viz.ai, a leader in AI-powered disease detection and care coordination, announced it will use its VizTM ...

Home March 04, 2023
Home
ACC23 CLEAR outcomes trial image
News | ACC
CLEAR Trial Reported at ACC23 Finds Bempedoic Acid Lowers LDL Cholesterol, Reduces Risk of Serious Cardiovascular Outcomes in Statin-Intolerant Patients

March 4, 2023 — The cholesterol-lowering drug bempedoic acid was found to reduce the combined rate of major adverse ...

Home March 04, 2023
Home
Late-breaking data presented at American College of Cardiology Scientific Sessions (ACC.23) and simultaneously published in The New England Journal of Medicine demonstrate TriClip was superior to medical therapy with significant improvements in quality of life and tricuspid regurgitation (TR)
News | Structural Heart
New Data Show Superiority of Abbott's TriClip Device Compared to Medical Therapy for Tricuspid Regurgitation

March 4, 2023 — Abbott announced late-breaking data for the TriClip transcatheter edge-to-edge repair (TEER) system, a ...

Home March 04, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now